← Eichor
Condition: Ibd Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Ibd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Phase N/A · 73 location(s) · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT03894228PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's
Phase 4 · 20 location(s) · University of Calgary · NCT05928039Health and Exercise Response in Children With Chronic and Auto-immune Pathologies
NA · 1 location(s) · University Hospital, Clermont-Ferrand · NCT03913962Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)
NA · 1 location(s) · University of Miami · NCT06784323Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05803980A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · 85 location(s) · Janssen Research & Development, LLC · NCT05923073Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06659588Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.
Phase 2 · 1 location(s) · Tanta University · NCT05575505Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi
Phase N/A · 4 location(s) · Meyer Children's Hospital IRCCS · NCT06862843Confirmatory Clinical Study in Active Ulcerative Colitis
Phase 2 · 16 location(s) · MRM Health NV · NCT07296315Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Cro
Phase 3 · 4 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04777656Top Down Versus Step up in Pediatric Ulcerative Colitis
Phase 4 · 1 location(s) · Children's Hospital of Fudan University · NCT04999228Ustekinumab With Semi-EN vs Exclusive EN for Preoperative Crohn's Disease Optimization.
NA · 1 location(s) · Xiang Gao · NCT06912815Digestive Biobank for Exploring Microbiota-host Interactions
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05704413Development of New Diagnostic Tools in Capsule Endoscopy
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06152289Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Dis
Phase N/A · 1 location(s) · Shanghai 10th People's Hospital · NCT07694674The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
Phase 2 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07507513Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07635394Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Phase N/A · 12 location(s) · TIDHI Innovation Inc. · NCT07245394AIRE-2 Device for Study of Breath Analysis in IBD
NA · 1 location(s) · McMaster University · NCT06541938Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Shmuel Kivity, MD · NCT07644117A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
Phase N/A · 38 location(s) · Pfizer · NCT06294925Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Phase 2/Phase 3 · 1 location(s) · Md. Hazrat Ali · NCT07114055Evaluation of the SMART IBD App in Pediatric IBD
NA · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07195123Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Phase 2 · 9 location(s) · Rambam Health Care Campus · NCT05599347Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07444060Prevalence and Impact of Sarcopenia in Patients With Inflammatory Bowel Disease
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT06300541Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Phase N/A · 1 location(s) · Brown University · NCT05754190Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
NA · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT06095596
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.